Nominations are now being sought for candidates to stand in the Royal College of Veterinary Surgeons Council and Veterinary Nurse Council (VN Council) elections. The deadline for nominations is 5pm on 31 January 2013.
Nick Stace, RCVS Chief Executive said: "Last year, a record number of veterinary surgeons showed by seeking a seat on RCVS Council that they were willing to help regulate their profession. The RCVS needs the efforts of willing vets and VNs to ensure that their professions continue to be well regulated. If you've thought about standing 'someday' - why not make someday now?"
There are six seats due to be filled on RCVS Council, and two on VN Council. Those elected will take their seats on RCVS Day next July, to serve four-year terms. Council members will be expected to spend at least six to eight days a year attending Council and Committee meetings, working parties and subcommittees (for which a loss-of-earnings allowance is available).
Each candidate needs to find two proposers; any veterinary surgeon or veterinary nurse (who is not presently on either Council) may propose one candidate for RCVS or VN Council respectively.
Nomination forms, full instructions and guidance notes are available from www.rcvs.org.uk/rcvscouncil13 and www.rcvs.org.uk/vncouncil13.
For the first time this year the RCVS will organise a webinar-style hustings event for RCVS Council candidates during the election period. This will offer candidates the opportunity to outline his or her manifesto verbally in a live event, with an audio-only recording. It will not be compulsory for candidates to take part, although it is hoped that the event will enable candidates to make their points in a way that will engage a broader range of voters than the paper manifestos alone.
Ceva Animal Health has launched ReprodAction, a new series of webinars to help address the problems commonly faced in bovine reproduction management.
James Husband, RCVS Specialist in Cattle Health and Reproduction, kicked off the series at the beginning of November with a live webinar for XLVet members: Assessing Fertility Records.
His presentation, which is now accessible to all large animal vets at http//onsync.digitalsamba.comn/go/ceva/ReprodAction, explores the common pitfalls and provides practical pointers for good fertility management. He discusses the limiting factors of oestrus detection, use of the calving interval as an assessor of individual fertility performance, implications of the varied definitions of conception rates, use of milk recording organisation data and the usefulness of the 21 day in calf rate.
Each webinar in the series is presented by a leading expert and has a facility for live chat and question and answer sessions.
For further information and details of when the next ReprodAction webinar will be taking place, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Webinar Vet Anthony Chadwick MRCVS (pictured right) has launched the UK's first virtual CPD congress for veterinary surgeons.
The event will 18 hours of CPD lectures via two live streams and one recorded stream. Anthony said: "Covering topics such as endocrinology with Prof Ian Ramsey, diagnostic imaging with Prof Mike Herrtage, and feline internal medicine with Dr Jane Armstrong, delegates will be able to jump-start their 2013 CPD in the most effective and efficient way!"
All three streams will also be available after the congress. Anthony said: "We have put a great programme together with top speakers from the UK, Australia and the USA. All of the sessions are being recorded and you will have access to all of the webinar after the event. This means delegates can watch one stream on the day and then the other lectures at their leisure."
The Webinar Vet International Virtual Congress is being held on Saturday 12th January 2013, between 9:30 - 4:30 pm GMT. It is open to non-members as well as members, at £97+VAT and £37+VAT respectively. For more details on the 18 lectures and to buy a ticket, visit http://www.theinternationalwebinarvet.com
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
The Kennel Club has announced that crossbreed dogs are to have their own event at Crufts for the first time next year.
For the first time in its twelve year history, the grand final of Scruffts, the crossbreed dog competition run by the Kennel Club, will culminate at Crufts at the NEC in Birmingham. The winners of the four Scruffts categories - Child's Best Friend, Golden Oldie, Prettiest Crossbreed Bitch and Most Handsome Crossbreed Dog - will battle it out for the ultimate title of Scruffts Family Crossbreed of the Year.
Scruffts, sponsored by James Wellbeloved, has held heats across the UK over the course of the year and the winners of each category in every heat have been invited to Discover Dogs in London to compete in the class finals on Saturday 10th November. Winners of the four classes at Discover Dogs will now go on to Crufts 2013, where they will compete for the overall Scruffts title.
Caroline Kisko, Secretary of the Kennel Club, said: "Scruffts is a fantastic competition and we're very much looking forward to seeing the four class winners come to Crufts for the final next year. We have had some fantastic Scruffts champions in the past and I am sure we can expect to see a really special dog take the title once again."
There is still time to qualify for the Scruffts class finals, with heats taking place at CSJ Canine Max 2012 in Cirencester Park on Saturday 13th October and the East of England Autumn Show in Peterborough on Sunday 14th October.
Norbrook Laboratories has launched Norfenicol Solution for Injection (florfenicol), a broad spectrum antibiotic licensed for the treatment of pneumonia in cattle and pigs.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "With many farmers preparing for winter housing, the launch of Norfenicol is timely as pneumonia represents the most common disease of housed cattle in the UK costing the agricultural industry an estimated £80m per year. Norfenicol is an easy to inject, cost effective treatment of pneumonia which kills bacteria quickly, and is available in a durable plastic bottle. Studies have shown florfenicol, the active ingredient in Norfenicol, to have a high bacteriological and clinical efficacy (100% and 96% respectively) against susceptible bacteria in the treatment of calf respiratory tract diseases."
Norfenicol is indicated for the treatment of bacterial respiratory disease in cattle associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somniand for the treatment of acute outbreaks of respiratory disease caused by strains of Actinobacillus pleuropneumoniae, and Pasteurella multocida in swine.
Dr McInerney added: "NSAIDs have also been shown to be a beneficial ancillary therapy in treating bacterial pneumonia, to alleviate pain as well as to reduce inflammation and pyrexia. Norbrook has a range of NSAID products which are available as an adjunctive treatment for pneumonia in cattle, including Loxicom 20 mg/ml solution for injection for cattle, pigs and horses."
For further product information, visit www.norbrook.com
Invicta Animal Health has launched SynVet-50, a licensed synthetic Sodium Hyaluronate (HA), for intra-articular treatment of lameness caused by joint dysfunction associated with non-infectious synovitis in horses.
The product is Invicta's first licensed medicine.
According to the company, the functional mechanisms of HA are directly dependent on the molecular weight and concentration of HA. 1 Therefore, SynVet-50 has been formulated with a molecular weight of 1.5m Daltons which is the highest of any synthetic HA available in the UK.
Invicta says that at 20mg per ml, SynVet-50 is also the most concentrated HA available.
Storage is at ambient temperature.
SynVet-50 is a 2.5ml solution containing 50mg HA, conveniently presented in a 5ml glass syringe.
Rob Watkins, Managing Director of Invicta said: "We are excited to be launching our first licensed medicine in the UK. The management team of Invicta have over 10 years experience in this market which has allowed us to provide a product strongly focussed on the clinicians needs, not just in terms of technical ability, but also in convenience of presentation".
For further information see www.invictavet.com or phone 01403 791313
Reference
The BVA has announced that from 2013, its annual Congress will take place at the London Vet Show.
The association says that the move is being done to bring together political debate and clinical CPD on a large scale and to ensure that the BVA can reach an even wider audience with its representative and educational services.
The BVA and the Vet Show teamed up last year at London Vet Show 2011 to announce the launch of the BVA Careers Fair, which will be hosted at this year's London Vet Show on 15-16 November, and the start of a partnership that would ensure discounted Vet Show rates for BVA members.
2013 will also see two new clinical streams added to the London Vet Show programme creating a comprehensive CPD event for vets in small and mixed practice. Cattle and equine streams for mixed practitioners will be delivered by the BVA to run alongside the popular companion animal stream provided by the Royal Veterinary College.
The partnership will also see substantial discounts being offered to BVA members.
BVA President Carl Padgett said: "BVA's number one value is that our members are at the heart of everything we do. We know that members require good value, high quality and relevant CPD and we believe that our new partnership with the London Vet Show offers the best opportunity for us to provide members with exactly what they want.
"It's a significant move for BVA but one that makes complete sense. From 2013 we will be bringing together the contentious issue streams that are the bedrock of BVA Congress, with a high quality clinical CPD programme covering large and small animals, and one of the biggest and best veterinary exhibitions.
"We know we haven't attracted the delegate numbers we would like to have done in recent years and by partnering with the London Vet Show we have the opportunity to reach a much greater audience. It's a very exciting step forward for BVA."
Rob Chapman, Event Director for the London Vet Show, said: "We are all delighted to be developing our relationship with the BVA. To be able to host such an established and prestigious event as the BVA Congress at the London Vet Show is an honour for the Vet Show.
"Combining the long-standing history of the BVA with the rapidly developing reputation of the Vet Show gives us a great symbiotic relationship. The new clinical content that we will be working on together will help the event and that relationship even further offering great value for both Vet Show delegates and BVA members."
Peter Harlech Jones has been elected President of the British Veterinary Association for 2012/2013. The ceremony took place during the Annual General Meeting of the BVA at the close of its Annual Congress, held in the Merseyside Maritime Museum in Liverpool.
Mr Jones, an international consultant on veterinary medicines, was born and raised in North Wales where he attended the Sir Huw Owen School in Caernarfon. He qualified from the University of Liverpool Veterinary School in 1971. After several years in practice in Wales and London - plus a spell in Ontario, Canada - Peter joined the pharmaceutical industry and spent 20 years in the animal health business both in the UK and overseas working in the fields of research and development and also regulatory affairs.
In 1995 he was appointed the first head of the Veterinary Division at the newly created European Medicines Evaluation Agency (EMEA) in London, playing a leading role in the creation of the new European regulatory system and working at the centre of European institutions. His last post before semi-retirement in 2008 was as head of the global animal health industry association, the International Federation of Animal Health (IFAH).
Within the BVA Peter has served on the Veterinary Policy Group and as chair of the Medicines Group and is a former secretary and chairman of the Association of Veterinarians in Industry (AVI). He participates in the work of the Federation of Veterinarians of Europe (FVE) and acts as a consultant to GALVmed whose aim is to make livestock vaccines, diagnostics and medicines accessible to those in developing countries for whom livestock is a lifeline.
Mr Jones said: "My background is in pharma research and international regulatory affairs and I am confident that my experience will be useful as we anticipate the new EU Animal Health Law and medicines legislation. But I am driven to do much more for the veterinary profession than just in those fields.
"The word 'value' really began to resonate for me when I started thinking of my theme for the year ahead as President of BVA.
"In whatever role we play vets are adding value in so many areas of our professional lives to society at large in a huge and significant contribution to the public good. I firmly believe that we, as an association and as a profession, must use every opportunity to reinforce the message about the value we give in all aspects of our work, and to believe in ourselves.
"I want to see a greater appreciation for what we do and what we contribute, and BVA will lead from the front.
"Looking ahead it will be a busy year for all of us. But I am confident that we have the teams in place - through our committees and council, our regional representatives, our divisions and beyond - to do our wonderful profession proud.
"I am certainly very proud to be standing here today and I am committed to working hard for all our members as their President."
The BVA Officer Team for 2012/13 is Peter Harlech Jones (President), Carl Padgett (Past President), and Robin Hargreaves (President Elect)
Pfizer Animal Health has launched Poulvac, the first modified live vaccine against E.coli in chickens.
The company claims that the vaccine, which can be used from one day of age, is set to bring major benefits in safeguarding the health of broilers, pullets for egg laying and breeding stock.
According to Pfizer, E.coli is one of the most significant bacterial pathogens found in chicks during the first week, leading to problems throughout the life of a flock including inferior performance, lack of uniformity and increased mortality. It is a costly, widespread problem for the UK poultry industry.
The vaccine was developed from research beginning in the 1990s at the Government's veterinary laboratories at Weybridge (now AHVLA) in the UK, employing genome technology to produce an avirulent strain of E.coli that induces protective immunity to the pathogenic strains of the bacteria.
The vaccine is completely non-pathogenic, and does not persist in the bird or the environment for any significant period of time. A gene deletion in its development restricts in vivo replication and leaves behind activated macrophages ready to respond to pathogenic E.coli strains.
Dr Stuart Andrews, poultry technical manager of Pfizer in the UK and Ireland said: "Poulvac E. coli provides broad cross protection against the key serotypes of E. coli infecting chickens. It is the only modified live, nonreactive vaccine proven to meet the European regulatory requirements for efficacy and safety.
"Trials have confirmed that Poulvac E.coli does not persist in the bird and proves to be self-limiting. The vaccine can survive in the environment for only a short time, and spread to in-contact birds is also limited."
The vaccine is administered as a coarse spray with onset of immunity 14 days afterwards and duration of immunity for up to 12 weeks. It can be used from day-old up to six weeks before the onset of lay, and has a nil day withdrawal period.
In the USA where Poulvac E coli has been available for six years field experience has shown the considerable benefits. In the Midwest where average layer mortality at 50 weeks of age was 2.31 per cent, this was reduced to 1.51 per cent with three doses of the vaccine*. In Eastern USA flock mortality compared with five previous flocks was reduced from over three per cent to one per cent.
A field trial in the USA with more than 300,000 broiler breeders vaccination before lay reduced mortality from 2.8 to 1.9 per cent - with only two out of 28 flocks needing antibiotic treatment compared with 13 of the 28 unvaccinated flocks.
On a broiler field trial in Georgia over four million birds were vaccinated with Poulvac E. coli at hatch. The vaccinated birds had a better feed conversion (1.79 against 1.84 for the controls) and with condemnations at the processing plant down from 1.22 to 0.73 per cent the result was a lower production cost of 0.51¢ per lb.
In another broiler trial covering more than two million birds in Arkansas livability was improved from 95.20 to 95.77 per cent and feed conversion improved from 1.95 to 1.90, gaining 0.45¢ per lb.
* Pfizer says it is important to note that in these studies carried out in the USA more than one dose of the vaccine was often administered. A single vaccination is licensed in the Summary of Product Characteristics however, where clinical disease requires and at the discretion of a veterinary surgeon, the vaccination schedule may be re-started as there is no contra-indication on the SPC.
The Royal College of Veterinary Surgeons Charitable Trust has awarded five new bursaries in its latest grants round.
Two student bursaries were for UK veterinary undergraduates to attend the British Science Festival in Aberdeen from 4-9 September 2012. The bursary winners were Liv Nathan (pictured on right), a third-year veterinary student at the Royal Dick School of Veterinary Studies, and Alahel Mahdmina, a second-year veterinary student at the Royal Veterinary College.
Liv said: "I am very enthusiastic about providing real-life context to science and giving people a space to consider issues arising around science."
The students were required to use their observations and experiences to help the Trust develop future outreach activities to inform and inspire public audiences about veterinary clinical practice and research. Their bursary packages covered all their attendance expenses over the four-day event. One of their achievements was to film an interview with Dr Maggie Aderin-Pockock MBE, a space scientist (pictured on left). Both students will be reporting back in full to the RCVS Charitable Trust with their ideas at the end of October.
Two further bursaries were given to attend a joint symposium on antimicrobial resistance (AMR): 'Antimicrobial Resistance in Human and Veterinary Medicine - One Health, One Problem' to be held at the Royal College of Physicians, London, on Tuesday 2 October 2012.
One winner was Cahir King, a practitioner from Downe Veterinary Clinic in County Down, Northern Ireland. He said: "It will be a privilege to attend a symposium at which so many experts in their field will be speaking. Any vet who has worked on farms will be more than familiar with bugs that are resistant to antibiotic treatment."
The other winner was James Swann, a Junior Clinical Training Scholar (Small Animal) at the Royal Veterinary College. James said: "I am particularly interested in the application of clinical audit in practice to assess problems like AMR, and design effective strategies to deal with them. I believe it should be possible to provide simple audit kits for practices to download and implement, removing much of the inertia that prevents such ideas from being initiated."
The bursary winners will be offered free delegate passes, including lunch, worth £90, and travel expenses.
The final bursary is to attend the Veterinary Biomedical and Pharma Sciences (VBMPS) Congress on 15-16 October, in Birmingham.
The winning entry was from Alexander Stoll, a final-year student at the Royal Veterinary College, who acted as the Royal Veterinary College and UK student ambassador to the European Commission for the 'One Health' message. The Trust was impressed with Alexander's enthusiasm and active engagement in subjects related to One Health. He is a member of the Royal Society for Public Health and a member of the Society of Biology.
Alexander said: "I hope to be inspired to enter a cross-disciplinary career path and also to communicate the potential of a One Health approach, inspired by this congress."
Alexander won a package that includes entry to the conference and admission to all scientific sessions, worth £175, as well as transport costs and overnight food and accommodation.
The University of Surrey has announced that it is to launch a new school of veterinary medicine in 2014.
According to the University, the new school will embrace the 'One Health - One Medicine' philosophy and will include the development of a unique research-led veterinary medicine degree programme with an emphasis on research, veterinary pathology and livestock medicine.
The new school will be based at the University of Surrey's Manor Park site in Guildford, in order to encourage collaboration of students and staff from different disciplines, with those studying towards a veterinary medicine qualification being exposed to engineering and physics as well as receiving training in core business skills.
The new School of Veterinary Medicine at Surrey will be delivered through collaborations with key partners including: the Animal Health and Veterinary Laboratories Agency (AHVLA), the BBSRC Pirbright Institute, the Veterinary Medicines Directorate (VMD), Fitzpatrick Referrals, Liphook Equine Hospital and Westpoint Farm Vets. The University says it is looking to extend its relationships with regional veterinary practices over the coming year.
Students will also be exposed to global issues concerning animal health through the University Global Partnership Network (UGPN), a trilateral agreement between Surrey, North Carolina State and São Paulo Universities through teaching collaborations, summer scholarships and research exchanges.
Professor Lisa Roberts, Dean of the Faculty of Health and Medical Sciences at the University of Surrey, said: "As a research-intensive University we have the expertise, reputation, technical and business skills which our students can benefit from, allowing us to train the veterinary leaders of the future. Combining state-of-the-art facilities, our unique partnerships and a campus location, the new School will provide a stimulating environment not only for undergraduates, but for the professional development training of qualified veterinary surgeons."
Professor John Fazakerley, Director of The Pirbright Institute, said: "This is good news for the UK veterinary research community. The Pirbright Institute currently works in close collaboration with the University of Surrey on research that benefits animal health and welfare; we very much look forward to building on this established and growing association as the new school of veterinary medicine is launched. There is an important place for trained veterinarians in scientific research and we are delighted that the University has decided to emphasise these areas in particular."
Professor Andy Durham of the Liphook Equine Hospital said: "The new School of Veterinary Medicine development programme at the University of Surrey is ideally timed to provide an alternative to the traditional veterinary education and to respond to the demands of a changing profession with fresh plans, ideas and enthusiasm. Enticing newly developed facilities make Guildford an excellent student town and with several collaborative specialist partners within the locality the new School of Veterinary Medicine is perfectly placed geographically to provide a veterinary education fitting for the 21st century."
The University is also in consultation with the Royal College of Veterinary Surgeons. Freda Andrews, Head of Education at the RCVS, said: "We were pleased to meet Professor Sir Christopher Snowden, President and Vice-Chancellor and his colleagues from the University of Surrey recently, and interested to hear their proposals to develop a new School of Veterinary Medicine. We will be working with them over the coming months to develop a timetable for considering the new programme against our accreditation standards. The monitoring process will take a number of years."
The University says it has already laid the foundations for the new School through its expansion of teaching and research activities in its Faculty of Health and Medical Sciences, including the launch of the BSc programme in Veterinary Biosciences in 2009 and in October of this year a new MSc in Veterinary Microbiology. A new MSc in Veterinary Pathology is also currently under development.
The University says that over the next 12 months it will be recruiting new academic staff, attracting the first cohort of students and beginning building works in preparation for the first cohort of students in 2014.
Companion Care Vets has announced it will work in partnership with VetAbroad, an e-learning company that has been established to help vets who qualified outside the UK to develop a successful career within it.
Companion Care is the first veterinary group in the UK to enter into partnership with VetAbroad, with the aim that all new non-UK employees will complete the course.
According to the company, almost 30% of vets registered in the UK are from overseas and statistics show that one in three will leave the register in less than 24 months and 20% in less than 12 months. Statistics also highlight the likelihood of a non-UK vet to be struck off or suspended is six times higher than for a UK vet.
Jane Balmain, Managing Director of Companion Care Vets said: "Whilst we as a company offer as much support as possible to our team members from overseas and support their continued learning , we are delighted to be working in partnership with VetAbroad to utilise their training solutions and further enhance what we offer to team members who come from overseas. All new employees will be required to take the course and we will also be encouraging our current overseas vets to complete it."
The e-course covers social and professional adaptation, compliance with current legislation, teamwork, productivity, client care and communication skills and VetAbroad states that those taking the course will substantially increase their chances of retaining and obtaining a job in the UK.
Vet and founder of VetAbroad Luis Sainz-Pardos said: "The primary aim of our course is to help vets who have qualified overseas to swiftly integrate into the UK system. Vets who have taken the course will be aware of UK legislation and should be able to interact with colleagues, clients and patients to a UK standard. As a result, the problems often associated with employing non-UK vets to work in UK practices are greatly reduced. I am thrilled to be working in partnership with Companion Care Vets, a company that I believe is thriving due to its investment in its most important asset - people."
For further information about VetAbroad please visit www.vetabroad.com
Phil Kenward from Farm Vets South West in Bridgewater, Somerset has won a bottle of port from the Veterinary Benevolent Fund for submitting the best practical veterinary tip.
The tip was:
"Do not allow the owner's diagnosis of his problem to worry or influence you before you examine the animal yourself."
The competition was run to celebrate the launch of The Pocket Book of Tips For Practising Vets which can be ordered on-line from the Vetlife website to raise funds for the VBF charity.
Lydia Brown, President of the VBF, said: "This book has been a monumental effort by six mixed practice vets, to both share their experience with the profession and to provide very welcome funds for the veterinary profession's own charity, the VBF. We are currently raising money for the new Vet Helpline e-mail support service which will launch at the end of the year so we are extremely grateful to everybody concerned for all their efforts."
A lecturer of special eminence in veterinary anatomy is sought for the 2013 RCVS Share Jones Lectureship.
This is a biennial award whose recipients give a public lecture on a subject agreed with the College.
Recent lectures have included 'Who says you can't be big and nimble? The fragility of giant land animals,' given in 2011 by Professor John Hutchinson, whose expertise includes the anatomy and locomotion of dinosaurs and crocodiles; and 'Sex and Regeneration: Lessons from Nature,' a study of deer antlers presented by Professor Jo Price.
Jo said: "It was a great privilege to be asked to deliver the Share Jones Lecture and it was an experience that I will remember as one of the highlights of my career. This lecture provides a unique opportunity for those of us with a deep interest in structure-function relationships to showcase the discipline of veterinary anatomy and inspire the next generation of veterinary scientists."
Any lecturer who has achieved special eminence in veterinary anatomy is eligible for nomination; RCVS membership is not a requirement. Nominations will be considered by the Education Policy and Specialisation Committee in February, with decisions made by RCVS Council in March. To nominate a candidate for the lectureship, please email his or her CV, with a letter of recommendation, to Ms Anne Jermey (education@rcvs.org.uk).
The Veterinary Marketing Association has announced a Practice Marketing Award, with a prize of £500 worth of CPD, for which entries are now being sought.
The award, which is sponsored by Merial, is open to companion and farm animal practices that can demonstrate effective marketing to their clients during the course of 2012.
For more information, visit: www.vma.org.uk/awards, or email: secretary@vma.org.uk for entry details.
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
Petplan has launched a video to promote its Veterinary Awards to the public.
Impressively, it has already notched up over 57,000 views on youtube.
Ceva Animal Health has announced that it is now accepting nominations for its annual Animal Welfare Awards.
The awards recognise veterinary surgeons, veterinary nurses and charity professionals who go the extra mile to prevent and reduce welfare problems for animals.
If you think one of your colleagues, vet or nurse, should be recognised for their work improving animal welfare, you'll need to nominate them before the 15th February 2013 deadline.
The awards include:
Winners of all awards will have a choice of luxury prize - ranging from spa weekends, European city breaks, countryside retreats or an animal experience. All individuals who nominate will be automatically entered into a prize draw to win £250 of high street vouchers. Ginette Bryant from Ceva, said: "The Ceva Animal Welfare Awards are an opportunity to recognise the hard work and dedication of individuals in the veterinary and animal charity industry. Our mission 'Together, beyond animal health', recognises that the health of animals, humans and the planet are inextricably linked, these awards are fitting way to work towards improving the health of all. "Whether it is improving animal welfare through client education in practice, championing good causes or helping specific cases, we know there are many people who share our ambitions in preventing and reducing companion animal welfare issues. It is these passionate individuals who are the unsung heroes of our industry and we're really excited to hear the inspiring stories from each nomination."
There are also three awards for people who work outside the veterinary or animal charity sector.
Nominations forms are available from www.ceva.com.
The deadline for entries is 15 February 2013.
For further details or additional nomination forms for your practice call Ceva on 01494 781 510 or email welfare.awards@ceva.com The awards ceremony will be held on Wednesday 3 April 2013 during the BSAVA conference in Birmingham.
Axiom Veterinary Laboratories has launched SLIT - sublingual immunotherapy treatment - for allergies in cats, dogs and horses.
According to the company, sublingual immunotherapy has been shown to be safe and effective in humans for over 20 years and a recent study has shown it to be a beneficial alternative way of administering immunotherapy to cats, dogs and horses, proving particularly effective in treating animals that failed to respond to allergy shots.
Patients can convert from shots to drops with an initial treatment kit.
Martyn Carpenter, Director of Axiom Laboratories Ltd, said: "Each ACTT Allergy Drop prescription is a custom formulation containing the specific allergens that are causing the pet's discomfort. Allergy drops are prepared in a glycerin solution to provide antigen stability, and have a slightly sweet taste, which assists in palatability and ease of administration. This method greatly reduces irritation and the likelihood of anaphylactic shock and can be administered easily at home by the client, freeing up consult slots and removing the stress which accompanies a visit to the surgery for many pets. This can be a particularly suitable alternative for those clients on a restricted budget, for whom on-going consult and injecting fees can be prohibitive to compliance with immunotherapy treatment. "
For more information, contact Axiom's Diagnostic Support Team on 01626 355655
The RCVS has launched a survey to discover what the profession thinks it does well and what it could improve upon.
The confidential online survey asks about your recent interactions with the College, what you think the organisation does well and what can be improved upon.
The survey is one of several activities that the College is undertaking as part of its First-Rate Regulator initiative. Others include a survey amongst those who have made complaints; research amongst RCVS staff and Council / VN Council members; in-depth phone interviews with veterinary surgeons, veterinary nurses and practice managers; and, questionnaires aimed at stakeholder organisations that work regularly with the College.
Desk-based research is also being carried out, to see how the RCVS shapes up when compared to other similar regulators, both in the UK and overseas.
Following this evidence-gathering stage, an assessment will be made about where gaps exist between how the College performs and what it ought to be achieving, together with recommendations for change.
Nick Stace, RCVS CEO said: "Becoming a first-rate regulator is the aim, building on the good things we do, and challenging ourselves to be better where we fall short."
"Although the RCVS has a long and proud history, we also need to have a sustainable future. Careful scrutiny of what we do, and how we can improve, will ensure this. I would urge all members of the veterinary team to take this unique opportunity to help improve the regulation of their professions."
The survey closes on 4 January 2013. All veterinary surgeons and veterinary nurses for whom the RCVS holds unique email addresses will be sent a link to the survey. Others are invited to visit www.rcvs.org.uk/firstratesurvey to take part. Practice managers, and student vets and VNs are also encouraged to complete the survey. Individuals who are not veterinary surgeons, nurses, students or practice managers, and who have views about how the College could improve, are invited to contact Nick Stace on nick@rcvs.org.uk.
BCF Technology has announced the launch of the Logiq S7 Expert ultrasound system.
BCF says the new system offers the latest in ultrasound technology and represents a significant leap forward in imaging capability.
The Logiq S7 ultrasound system includes features such as B-Flow, Elastography, Flow Quantification, Contrast Imaging, B-Steer+, 3D/4D ultrasound, Volume Imaging and Multi-Modality Imaging Display.
Nigel Perry from BCF said: "The new Logiq S7 Expert provides the highest image quality currently available in the market. With a wide range of probes available for every veterinary application. If you are looking for the ultimate in ultrasound capability then the Logiq S7 is the system for you."
For more information, visit http://www.bcftechnology.co.uk/ or call +44(0)1506 460 023.
Bayer Animal Health has produced a take home prescription guide to encourage pet owners to remain compliant with its antimicrobial, Veraflox (pradofloxacin).
The leaflet contains prescription details together with a treatment record and next appointment reminder. Group Product Manager Tracey Dawson said: "There is also a FAQ (frequently asked questions) section explaining why compliance is so important."
Bayer says the leaflet has been developed to help vets and VNs ensure pet owners are encouraged to be responsible with prescribed medicines. Tracey added: "The guide is designed to reinforce the information given by the prescribing vet, and answer further questions owners might have on arrival home or during the treatment."
Bayer highlights that Veraflox's mode of action helps reduce the potential for the development of resistant bacteria¹, but only if it is used correctly. Tracey said: "Although it might seem to be easy for pet owners to adhere to the advice given with prescribed medicines, especially with the more palatable options now available, it is very important that we help preserve the efficacy of the fluoroquinolone class by continuing to encourage strict client compliance through correct dosing, and finishing the course of antibiotics prescribed."
For further information, contact your Bayer Territory Manager or call Bayer Animal Health on 01635 563000.
Wetzstein HG. Comparative Mutant Prevention Concentrations of Pradofloxacin and Other Veterinary Fluoroquinolones Indicate Differing Potentials in Preventing Selection of Resistance. Antimicrob Agents Chemother. 2005;49(10): 4166-4173
Vetoquinol has announced that the vouchers it provides as part of the Epiphen practice support package for monitoring and management of serum levels of phenobarbital will now be provided directly from the veterinary wholesaler and sent with each order.
One or two vouchers are provided with the 30ml and 60ml packs respectively. The vouchers come complete with a pre-paid envelope in which to send samples directly to the laboratory. Each test is valued at £19.80
For further information, contact your local Vetoquinol Territory Manager.
Petplan has announced that nominations are now open for its 14th annual Veterinary Awards.
The awards recognise members of the veterinary community who have gone above and beyond in their daily role.
According to the company, one in three pets make an unexpected trip to the vet each year, making vets the unofficial 4th emergency service. A quarter of pet owners consider their vet a good friend with 42% on first name terms. 98% of Petplan customers have said that they trust their vet; with many saying that they are more trustworthy than police officers - coming second only to doctors.
Petplan's Head of Marketing, Isabella Von Mesterhazy said: "At Petplan, we hear from our customers every day about the exceptional service veterinary staff have given to pets in their care. The Veterinary Awards are an opportunity for Petplan to show our support to members of this profession and thank these hard-working individuals on a national scale. We want to encourage pet owners across the UK to nominate their veterinary stars this year to show their appreciation for all their tireless effort to keep the nations pets fit and healthy."
To make nominate a vet, vet nurse, vet practice and other members of the veterinary team visit www.petplan.co.uk/vetawards before 31st January 2013. The winners will be announced at the ceremony held in Birmingham on 4th April 2013.